MedTrace Logo

Uroflowmetry and Nocturnal Enuresis

NCT07028645 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2025-06-24

No results posted yet for this study

Summary

This study will evaluate the uroflowmetry parameters of patients which were treated for enuresis.

Conditions

  • Enuresis, Nocturnal

Interventions

DRUG

desmopressin melt form 120 μg

Desmopressin 120 mcg will be used frist-line drug in the treatment of enuresis.

DRUG

Desmopressin lyophilisate (Melt)

Desmopressin 240 mcg will be used for the patients who have not responsive to desmopressin 120 mcg.

DRUG

Propiverine tablet

Propiverine (a dose of 0.8 mg/ kg) will be used for the patients who have -response to treatment with desmopressin 240 mcg

Sponsors & Collaborators

  • Furkan Adem Canbaz

    lead OTHER

Eligibility

Min Age
5 Years
Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-20
Primary Completion
2024-09-01
Completion
2025-12-30
FDA Drug
Yes

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07028645 on ClinicalTrials.gov